Show simple item record

dc.contributor.authorOutterson, Kevinen_US
dc.date.accessioned2021-06-08T12:36:16Z
dc.date.available2021-06-08T12:36:16Z
dc.identifier.urihttps://hdl.handle.net/2144/42657
dc.description.abstractThis is the Excel file accompanying the paper, to be published in Clinical Infectious Diseases 2021en_US
dc.description.sponsorshipn/aen_US
dc.language.isoen_US
dc.rightsThe work is distributed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 license.en_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/
dc.subjectAntibacterial resistanceen_US
dc.subjectResearch and developmenten_US
dc.subjectAccessen_US
dc.subjectAccess to medicineen_US
dc.subjectCommercial launchen_US
dc.titleAccess to antibacterials approved 2010 - 2019en_US
dc.typeDataseten_US


This item appears in the following Collection(s)

Show simple item record

The work is distributed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 license.
Except where otherwise noted, this item's license is described as The work is distributed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 license.